Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M107888200 on October 1, 2001

J. Biol. Chem., Vol. 276, Issue 49, 45772-45779, December 7, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45772    most recent
M107888200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Cockayne Syndrome Group B Gene Product Is Involved in General Genome Base Excision Repair of 8-Hydroxyguanine in DNA*

Jingsheng TuoDagger , Meltem MüftüogluDagger , Catheryne ChenDagger , Pawel Jaruga§, Rebecca R. SelzerDagger , Robert M. Brosh Jr.Dagger , Henry RodriguezDagger , Miral DizdarogluDagger , and Vilhelm A. BohrDagger ||

From the Dagger  Laboratory of Molecular Gerontology, NIA, National Institutes of Health, Baltimore, Maryland 21224 and the § Chemical Science and Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899-8311

Received for publication, August 16, 2001, and in revised form, September 17, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cockayne Syndrome (CS) is a human genetic disorder with two complementation groups, CS-A and CS-B. The CSB gene product is involved in transcription-coupled repair of DNA damage but may participate in other pathways of DNA metabolism. The present study investigated the role of different conserved helicase motifs of CSB in base excision repair. Stably transformed human cell lines with site-directed CSB mutations in different motifs within its putative helicase domain were established. We find that CSB null and helicase motif V and VI mutants had greater sensitivity than wild type cells to gamma -radiation. Whole cell extracts from CSB null and motif V/VI mutants had lower activity of 8-hydroxyguanine incision in DNA than wild type cells. Also, 8-hydroxyguanine accumulated more in CSB null and motif VI mutant cells than in wild type cells after exposure to gamma -radiation. We conclude that a deficiency in general genome base excision repair of selective modified DNA base(s) might contribute to CS pathogenesis. Furthermore, whereas the disruption of helicase motifs V or VI results in a CSB phenotype, mutations in other helicase motifs do not cause this effect. The biological functions of CSB in different DNA repair pathways may be mediated by distinct functional motifs of the protein.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cockayne Syndrome (CS)1 is an autosomal recessive human disorder with diverse clinical symptoms that include hypersensitivity to sunlight, severe mental and physical growth retardation, microencephaly, progressive neurological and retinal degeneration, and skeletal abnormalities (1, 2). Genetic analysis of fused heterodikaryons has identified two complementation groups of CS, designated as CS-A and CS-B. The CSA and CSB genes have been cloned, and the basic structure and function of the genes have been characterized (3-5).

Studies using skin-originated CS-B fibroblast cells demonstrated an increased sensitivity to UV radiation, accompanied by a delay in RNA synthesis recovery (1, 6). The hypersensitivity of CS to UV radiation is attributed to a pronounced defect in the repair of DNA damage triggered by UV radiation (7). The predominant DNA damage introduced by UV radiation is the generation of cyclobutane pyrimidine dimers and 6-4 photoproduct adducts. These lesions are bulky and helix-distorting and can be removed by nucleotide excision repair (NER) in a transcription-coupled repair (TCR) pathway (8-12). It is generally believed that the inherited defects in TCR of NER constitute the molecular basis of CS (13, 14). However, the UV sensitivity alone may not explain the progressive neurodegeneration and other clinical appearances in CS because short wavelength radiation like UV cannot reach the inner organs and tissues. Thus, TCR of NER is unlikely to be the only pathway defective in CS. There are indications that CSB also plays a role in transcription and chromatin remodeling (9, 15).

It has been proposed that oxidative damage to DNA plays a vital role in the development of progeroid syndromes (16). Living organisms are constantly exposed to oxidative stress from environmental agents, including ionizing radiation, and from endogenous metabolic processes. A significant consequence of oxidative stress is DNA base modifications, which can result in mutations and other types of genomic instability. 8-Hydroxyguanine (8-OH-Gua) is one of the principal modified bases in DNA resulting from oxidative damage, and it is repaired mainly by the process of base excision repair (BER) (17, 18). Although TCR is responsible for processing some types of oxidative DNA damage in studies using CSB as a model (19-22), alternative pathways for the function of CSB in the repair of DNA base modifications remain to be further elucidated. This laboratory reported that whole cell extract (WCE) from primary CSB cells incised 8-OH-dGuo at a reduced level in comparison with normal cell lines and that this BER deficiency in primary CS-B cells is associated with a down-regulated transcription of the human 8-hydroxyguanine glycosylase/apurinic site lyase (hOgg1) gene (18). This deficiency can be complemented by transfection of the cells with the normal CSB gene (18).

The human CSB gene encodes a protein of 1493 amino acids with a molecular mass of 168 kDa (5, 23). By sequence homology, the CSB gene product belongs to the SWI2/SNF2 family of proteins. All proteins in this family contain seven putative consecutive DNA and RNA helicase motifs (24) (see Fig. 1). In addition to the helicase motifs, CSB contains an acidic amino acid stretch, a glycine-rich region, and two putative nuclear localization signal sequences (5) (see Fig. 1). Despite the presence of the conserved motifs, CSB has not been demonstrated to possess helicase activity as defined experimentally by an ability to unwind double-stranded DNA in a classic strand displacement assay (25). As are other members of the SWI/SNF subfamily, CSB is likely to be involved in a wide variety of cellular functions, including DNA repair, transcription regulation, maintenance of chromosome stability, and chromatin remodeling (9, 26). However, limited information is available that addresses the functional significance of the individual motifs. The characterization of motif II of CSB in DNA repair has been performed by the construction of a point mutation in motif II in hamster cells (27). The motif II mutant lost the ability to confer cellular resistance to 4-nitroquinoline-1-oxide (4-NQO) and UV exposure. Because motif II functions in ATP hydrolysis, the cellular data suggested that ATP hydrolysis by CSB was essential to certain types of DNA repair, for example the TCR of NER (27). Recent studies in this laboratory have shown that the BER of 8-OH-Gua was deficient in CSB null cells. However, we have found no evidence for a function of motif II in BER.2

To gain further understanding of the importance of CSB protein in BER, site-specific mutations were introduced in various helicase motifs of the CSB protein in human cells. Stably transfected CS-B cell lines with altered CSB genes were established by transfecting plasmids containing a site-directed CSB mutation into CS1AN cells, a human CS-B fibroblast. The cell lines were tested for their sensitivity to oxidative stress, the ability of whole cell extract to repair modified DNA bases in vitro, and the accumulation of modified bases in genomic DNA after oxidative stress. We report here that CSB plays a role in lesion-specific BER and that helicase motifs V and VI of CSB are crucial in this function. We also find that mutations in certain motifs of CSB in human fibroblast lines lead to the accumulation of oxidative DNA base lesions in cells that have been exposed to oxidative stress.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines and Culture Conditions-- All cell lines were derived from CS1AN.S3.G2, a SV40-transformed human fibroblast cell line belonging to CS complementation group B. The characteristics of the cells have been previously described (28). The sensitivity of each cell line to UV was tested before use. CS1AN.S3.G2 transfected with the mammalian expression vector pcDNA3.1 alone (Invitrogen; abbreviated as pc3.1) or pcDNA3.1 containing intact or constructed mutated CSB gene are designated in Fig. 1. A neomycin resistance gene in the pc3.1 plasmid was used for the selection. All cell lines were routinely grown in minimal essential medium supplemented with 15% fetal bovine serum, 0.3 mg/ml L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, and 400 µg/ml geneticin (G418, Life Technologies, Inc.).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of CSB protein and the location of the designed mutants. The protein contains the seven conserved helicase motifs, a highly acidic region, and two nuclear localization signals (NLS).

Establishment of Stable Transfected Cell Lines with Site-directed Mutations in CSB-- Site-directed mutagenesis of CSB was performed by a uracil containing DNA based protocol (27, 29). The plasmid pcBLsSE6 with the entire human CSB cDNA was kindly provided by Dr. Jan Hoeijmakers. Mutations in CSB were constructed to replace highly conserved residues in motifs Ia, III, IV, and VI of the putative helicase domain and in the second putative nucleotide-binding (NTB) domain. The design of most of the constructs is presented elsewhere.3 The newly made CSBR946A was constructed by replacing arginine with alanine using primer 5'-CTCCATGCTGCCTCCCGGGCC-3'. After verification by sequencing, the wild type or mutated CSB genes were cloned into the mammalian expression vector pc3.1 and transfected into CS1AN.S3.G2 using SuperFect Transfection Reagent (Qiagen, Santa Clarita, CA). The cells were selected with complete medium containing geneticin (400 µg/ml). Individual colonies were screened for expression of the CSB transcript.

Analysis of CSB Expression in the CSB Transfectants-- The entire CSB transcript in the transfectant clones was verified by PCR. RNA was extracted using RNA STAT-60 (Tel-Test Inc., Friendswood, TX) followed by treatment with RNase-free DNase I (Roche Molecular Biochemicals). cDNA was synthesized by using a reverse transcription kit (RETROscript, Ambion, Austin, TX) with equal amounts of total RNA (5 µg) from various cell lines according to the manufacturer's recommendation. A high fidelity PCR master kit (Roche Molecular Biochemicals) was used for PCR amplification of cDNA products. The CSB (4.7 kb) cDNA was amplified as six overlapping fragments using primers and annealing conditions as previously described (27, 30). PCR products were detected by electrophoresis on agarose gels with ethidium bromide staining (Fig. 2A).


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 2.   Verification of CSB transfected cell lines by RT-PCR and Western blot. A, the RT-PCR products of mRNA of CSBR946A. The molecular weight marker was DNA marker IV from Roche. Lane 1 is the positive control of RT-PCR. Lanes 2-7 are the products amplified by primers 6F/6R, 5F/5R, 4F/4R, 3F/3R, 2F/2R, and 1F/1R, respectively, which cover different segments of the whole CSB gene. bp, base pairs. B, CSB protein was detected with Western blot. All mutant cell lines expressed CSB protein in a relatively equal level to wild type. There was no detection of CSB in WCE of CS1AN/pC3 (CSB null).

Relative quantitative RT-PCR was processed for comparing relative transcript abundance standardized by coamplification of CSB fragment and highly conserved fragments of 18 S rRNA from the transfected cell lines. The RNA isolation and cDNA synthesis were as described above. The primers 5'-GGTGTTAGGTGGCTGTGGGAATT-3' and 5'-GTATCTCGTAAGACACACATGCACAC-3' were used to produce a 671-base pair product from CSB mRNA (27, 30). The amplification using primers for 18 S ribosomal RNA produced a 488-base pair fragment. The linear range of PCR cycles for CSB was determined by titrating synthesized cDNA. For PCR amplification, 0.5 unit of AmpliTaq Gold (Applied Biosystems) was used according to the manufacturer's procedures. In addition to standard reaction components, PCR mixtures contained 0.2 µM of CSB primers, 0.2 µM of 18 S RNA primer:competimer (4:6) (QuantumRNA Classic 18S, Ambion, Austin, TX) in a total volume of 50 µl. PCR hot start was 5 min at 80 °C, 5 min at 49 °C, 1 min at 94 °C, followed by 39 cycles consisting of 30 s at 94 °C, 45 s at 67 °C, 1 min at 72 °C, and one final extension cycle for 7 min at 72 °C. The ratio of CSB transcript and 18 S rRNA was determined by running 1% agarose gels and scanning with the ImageQuant software (Molecular Dynamics, Sunnyvale, CA).

WCEs were used to evaluate the CSB protein expression. These WCEs were prepared as previously described (31). Equal amounts of protein (100 µg) were loaded on 3-8% polyacrylamide gels (NuPAGE) and resolved at 200 V for 1.5 h in NuPAGE Tris-acetate SDS running buffer (Invitrogen). The proteins were transferred onto a polyvinylidene difluoride membrane at 100 V for 1 h at 4 °C in NuPAGE transfer buffer (Invitrogen). CSB was detected with human anti-ERCC6 IgG fraction monoclonal antibody (1:1000, Austral Biologicals, San Ramon, CA) and then hybridized with a peroxidase labeled anti-mouse IgG antibody (1:1000). The membrane was developed with a chemiluminescent substrate (ECL+ kit, Amersham Pharmacia Biotech) and then evaluated with a Molecular Dynamics PhosphorImager.

Clonogenic Assay-- Five hundred cells were seeded in 10-cm2 dishes and allowed to attach overnight. For UV and gamma -radiation, cells were washed with phosphate-buffered saline and then irradiated at the indicated doses with a UV lamp (254 nm) or with a Gammacell 40 Exactor 137Cs gamma -source (Nordian International Inc., Kanata, Canada) and returned to complete medium. For 4-NQO treatment, the cells were washed and incubated with the indicated dose of 4-NQO in serum-free minimal medium for 30 min at 37 °C and then washed with phosphate-buffered saline and returned to complete medium. The cells were grown for 10 days, washed once with phosphate-buffered saline, fixed with methanol, and stained with methylene blue for colony counting. Three independent experiments were carried out with three parallel samples for each dose. The area under the curve (AUC) was used as the comprehensive survival index of each cell line and was calculated according to the trapezoid rule using software GraphPad Prism version 3.02 (32).

Glycosylase/Apurinic Lyase Activities (Incision) on Oligonucleotides with Modified Bases in WCE from CSB Transfected Cell Lines-- The following oligonucleotides with a single lesion of 8-OH-Gua, 5-hydroxycytosine (5-OH-Cyt), or uracil at position 11 were employed (Midland Certified Reagent Co., Midland, TX): 5'-ATATACCGCG[8-OH-Gua]CCGGCCGATCAAGCTTAT-3', 5'-ATATACCGCG[5-OH-Cyt]CCGGCCGATCAAGCTTAT-3', and 5'-ATATACCGCG[Uracil]CCGGCCGATCAAGCTTAT-3'. All oligonucleotides were 32P-5'-end-labeled and annealed with the complementary strand as previously described (33). An oligonucleotide with the same sequence as above but with a normal CG pair at the relevant position instead of the modified nucleotide was used as the control.

Incision reactions contained 0.15 nmol of oligonucleotide duplex, 1 µg of poly(dI-dC) competimer, 20 mM HEPES-KOH, pH 7.8, 100 mM KCl, 5 mM dithiothreitol, 5 mM EDTA, 2 mM MgCl2, and 20 µg of WCE protein prepared as described (31). After incubation at 37 °C for the indicated time, the reactions were terminated by the addition of 0.8 µl of 10% SDS and 0.8 µl of 5 mg/ml proteinase K and incubated for 10 min at 55 °C. In a 20-µl reaction mixture, DNA precipitation was carried out by adding 4 µl of 5 mg/ml glycogen (Ambion), 8 µl of 11 M ammonia acetate, and 135 µl of cold ethanol followed by incubation overnight at -20 °C. The samples were centrifuged for 1 h at 4 °C followed by washing with 500 µl of 70% ethanol. After centrifuging at 12,000 × g for 10 min, the pellet was dried and resuspended in 10 µl of formamide loading dye (5% EDTA, 0.02% bromphenol blue, 0.02% xylene cyanol in 95% formamide), and the samples were separated by 20% denaturing polyacrylamide gel electrophoresis (containing 7 M urea, 89 mM Tris borate, pH 8.0, and 2 mM EDTA). The reaction products were visualized by autoradiography and quantified on a PhosphorImager (Molecular Dynamics) using ImageQuant software.

Measurement of 8-OH-Gua in Genomic DNA by Liquid Chromatography/Mass Spectrometry-- Liquid chromatography/isotope-dilution mass spectrometry was used to determine the accumulation of 8-OH-Gua in genomic DNA after exposure to gamma -radiation. This technique measures the nucleoside form of 8-OH-Gua, i.e. 8-hydroxy-2'-deoxyguanosine (8-OH-dGuo) (34). After irradiation at the indicated doses in a Gammacell 40 Exactor 137Cs gamma -source, the cells were incubated in the complete medium at 37 °C for 30 min. Cell pellets were resuspended in lysis buffer (0.5 M Tris, pH 8.0, 20 mM EDTA, 10 mM NaCl, 1% SDS, and 0.5 mg/ml proteinase K) and incubated at 37 °C overnight. Nuclear DNA was isolated by the salt extraction procedure (35, 36). The introduction of 8-hydroxy-2'-deoxyguanosine-8-18O, the digestion of DNA to nucleosides and the optimization of liquid chromatography/mass spectrometry parameters were performed as described (34).

Statistics-- Groups were compared by means of one-way analysis of variance tests. Duncan's multiple range test was used for post hoc comparison of means. Differences were considered significant when p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Characterization of the CSB Transfected Cell Lines-- The validity of the CSB transfected cell lines was evaluated by sequencing and RT-PCR. All six overlapping segments of CSB were detected from cDNAs of CSB transfected cell lines (Fig. 2A, from CSBR946A). The efficiency of CSB expression was examined by quantitative RT-PCR. The ratios of CSB transcript to 18 S internal standard were similar in all CSB transfected cell lines (data not shown). Similar levels of the CSB protein were detected by immunoblot analysis in extracts from the CSB transfected cell lines (Fig. 2B). No band corresponding to the CSB protein was detected in the CSB null cell line (Fig. 2B). These data showed that the intact CSB protein was expressed in all CSB transfected cell lines. Because UV sensitivity is a typical characteristic of CSB null cell lines and because we have previously reported that CSB null cell lines are also sensitive to 4-NQO (27), all CSB transfected cell lines were tested for sensitivity to those two agents by clonogenic assay. The typical survival curves are presented in Fig. 3. These data are from the CSB transfected cell lines containing a point mutation in motif VI, CSBR946A. Cells with mutations in motifs V and VI of the putative helicase domain were unable to complement the UV and 4-NQO sensitivity in comparison with wild type CSB. The helicase motif Ia and III mutants demonstrated an intermediary level of UV and 4-NQO sensitivity. The second putative NTB domain mutant showed UV and 4-NQO resistances equivalent to that of wild type CS-B cell line.3


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Clonogenic survival after UV (A) and 4-NQO (B) treatment of indicated CSB transfected cell lines. The percentage of survival after UV and 4-NQO treatments were calculated as the fraction of the irradiated cells to the nonirradiated cells plotted against dose. The values represent the averages, and the error bars represent the standard deviation from at least three independent experiments.

Sensitivity to Oxidative Stress of the Transfected CSB Cell Lines-- The colony forming ability of CSB transfected cell lines after gamma -radiation is shown in Fig. 4. CSB null cells were the most sensitive to gamma -radiation. The AUC of CSB null cells was 62% of that of wild type cell. CSBQ942E and CSBR946A (motif VI mutants) were unable to complement the gamma -radiation sensitivity of CSB null cells. AUCs of motif VI mutants were ~68% of that of wild type cells and were similar to that of CSB null cells. CSBT912V and CSBT912/913V (motif V mutants) partially complemented the gamma -radiation sensitivity of CSB null cells. AUCs of the motif V mutants were 84% of the wild type cell. The motif Ia mutant, CSBP573A, the motif III mutant, CSBQ678E, and the second putative NTB mutant, CSBK1137Q, demonstrated gamma -radiation resistance equivalent to that of wild type cells. A higher dose of gamma -radiation (3 Gy) led to larger survival differences between wild type cells and motif VI mutants.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   Clonogenic survival after gamma -radiation of indicated CSB transfected cell lines. The percentage of survival after gamma -radiation was calculated as the fraction of the irradiated cells to the nonirradiated cells plotted against dose. The values represent the averages, and the error bars represent the standard deviation from at least three independent experiments. The AUC was calculated by the trapezoid rule and is presented in parentheses.

Glycosylase/Apurinic Lyase Activities (Incision) on Oligonucleotides Containing a Single Base Modification in WCE from the CSB Transfected Cell Lines-- The 8-OH-Gua incision activities in WCEs from various transfected CS-B cell lines are shown in Fig. 5A, and the results from 4 independent experiments are summarized in Fig. 5B. We found reduced 8-OH-Gua incision activity in WCEs from CSB null cells (~33% of that of CSBWT, p < 0.05), from motif VI mutants (CSBQ942E and CSBR946A, ~50% of that of CSBWT, p < 0.05), and from motif V mutants (CSBT912V and CSBT912/913V, ~76% of that of CSBWT, p < 0.05). The 8-OH-Gua incision activity in WCEs from the motif Ia mutant (CSBP573A), motif III mutant (CSBQ678E), and the second putative NTB mutant (CSBK1137Q) were equivalent to that of wild type CSB. A time course experiment further substantiates this difference. The relative incision activities of 8-OH-Gua among the transfected cell lines (CSB WT>mutants>CSB PC3.1) were similar at all time points. The time course curves of the most 8-OH-Gua incision-deficient cell lines are presented in Fig. 5C. Reduced 8-OH-dGuo incision in CSBQ942E and CSB PC3.1 was observed at all time points analyzed. The largest differences were at 3 h when the reaction was close to saturation.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Glycosylase/apurinic lyase activities (incision) of 8-OH-Gua in WCEs from various CSB transfected cell lines. A, denaturing polyacrylamide gel graph; the 29-mer band was the substrate, whereas the 11-mer band was the product. The reaction was carried out for 3 h. B, the average of the conversion rate of 29-mer to 11-mer from four independent experiments. An asterisk denotes a value significantly different from CSBWT (p < 0.05). C, time course of 8-OH-Gua incision activities in WCEs from the most deficient CSB transfected cell lines.

The in vitro 8-OH-Gua incision activities of WCEs from the CSB transfected cell lines were then compared with their individual in vivo gamma -radiation survival (Fig. 6). This analysis showed a strong correlation between the cellular resistance to radiation (AUC from the survival curve of individual cell line) and the ability to incise 8-OH-Gua (percentage of incision). The motif contribution to 8-OH-Gua glycosylase/apurinic lyase activities paralleled the gamma -radiation resistance with a good correlation (r = 0.98, p < 0.05) (Fig. 6). Thus, the defect in 8-OH-Gua incision correlates with an increased sensitivity to gamma -radiation.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Correlation of in vitro 8-OH-Gua incision activities of WCEs and in vivo gamma -radiation survival of various CSB transfected cell lines.

To determine whether the BER defect was general or limited to the removal of 8-OH-Gua, we assayed for the incision of two lesions recognized by other glycosylases. There were no apparent differences among the cell lines in incision activities of either 5-OH-Cyt or uracil in oligonucleotide duplex (Figs. 7A and 8A). The cell lines with the most 8-OH-Gua incision deficiency (CSBQ942E and CSBPC3.1) appeared to have normal 5-OH-Cyt and uracil incision at all tested time points (Figs. 7B and 8B). Incision activities of both 5-OH-Cyt and uracil were close to saturation at 60 min. Thus, the BER deficiency in the transfected CS cell extracts appeared to be specific for certain damage(s). Incidentally, the incision activities of 5-OH-Cyt and uracil were both higher than that of 8-OH-Gua in all WCEs. Also, the identical level of the incision activities of 5-OH-Cyt and uracil in various cellular extracts suggested that the cell extracts all functioned proficiently and similarly with regards to DNA repair incision.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 7.   The glycosylase/apurinic lyase activities (incision) of 5-OH-Cyt in WCEs from various CSB transfected cell lines. A, denaturing polyacrylamide gel graph; the 29-mer band was the substrate, whereas the 11-mer band was the product. The reaction was carried out for 60 min. B, time course of 5-OH-Cyt incision activities in WCEs from the most 8-OH-Gua incision-deficient CSB transfected cell lines.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 8.   The glycosylase/apurinic lyase activities (incision) of uracil in WCEs from various CSB transfected cell lines. A, denaturing polyacrylamide gel graph; the 29-mer band was the substrate, whereas the 11-mer band was the product. The reaction was carried out for 60 min. B, time course of uracil incision activities in WCEs from the most 8-OH-Gua incision deficient CSB transfected cell lines.

Accumulation of 8-OH-Gua in Genomic DNA from Transfected CSB Cell Lines after gamma -Radiation-- Quantification of 8-OH-Gua in genomic DNA as its nucleoside form 8-OH-dGuo was performed by liquid chromatography/isotope-dilution mass spectrometry with selected ion mode. Fig. 9A illustrates the typical ion current profiles at m/z 168 (8-OH-dGuo) and m/z 170 (8-hydroxy-2'-deoxyguanosine-8-18O). There was no difference between the levels of 8-OH-dGuo in genomic DNA before exposure to gamma -radiation (0 Gy) of all tested cell lines (Fig. 9B). However, significantly greater (50-80%) levels of 8-OH-dGuo in DNA from two motif VI mutants and CSB null cells were observed 30 min after exposure to gamma -radiation at a dose of 2 Gy (p < 0.05), thus demonstrating that 8-OH-dGuo accumulated in these mutants relative to wild type.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 9.   Accumulation of 8-OH-dGuo in genomic DNA of the indicated cell lines 30 min after exposure to 2 Gy of gamma -radiation. A, selected ion-current profiles at m/z 168 (8-OH-dGuo) and m/z 170 (8-OH-dGuo18O) obtained during liquid chromatography/mass spectrometry with selected ion monitoring analysis of an enzymatic hydrolysate of DNA. B, the levels of 8-OH-dGuo in DNA of the indicated cell lines. The data were from four independent experiments. An asterisk denotes a value significantly different from CSBWT (p < 0.05).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study, human fibroblast cell lines with site-directed mutations of the CSB gene in various motifs of its helicase signature were generated by replacing the highly conserved amino acids in specific motifs of CSB. The aim was to elucidate the biological importance of the intact CSB gene and of the specific motifs within this gene in BER. The results demonstrate that the integrity of the CSB gene is important for cellular resistance to gamma -radiation. Amino acid substitutions in helicase motifs V and VI diminished the cellular resistance to gamma -radiation. In the in vitro assay of BER of certain lesions by WCE, the absence of an intact CSB gene resulted in deficient glycosylase/apurinic lyase activity of 8-OH-Gua in DNA but did not affect the incision of 5-OH-Cyt and uracil in DNA. Mutations in helicase motifs V and VI of CSB resulted in reduced 8-OH-Gua glycosylase/apurinic lyase activity. Furthermore, CSB null or helicase motif VI mutant cells showed a higher accumulation of 8-OH-Gua in genomic DNA after exposure of the cells to gamma -radiation.

The resistance of the CSBWT cell line to diverse types of DNA damaging agents that are repaired by TCR or general genome repair suggests that this gene is involved in more pathways than TCR of active genes. Whereas UV radiation-induced photoproducts are removed by TCR of NER, both 4-NQO and gamma -radiation generate modified DNA bases that are repaired without strand bias (37, 55), e.g. the pathway of global genome repair (38). Recently, TCR of 8-OH-Gua was observed using an 8-OH-Gua-containing extrachromosomal plasmid model, and the process was associated with multiple proteins (20, 21, 39).

Although the integrity of CSB is important for cell survival, different conserved helicase motifs did not contribute equally to the function. We have previously reported differences in the functional importance of motif II and the acidic region of CSB in the resistances to UV and other DNA damaging agents (40).2 We have now established seven transfected human cell lines with mutations distributed in the four conserved helicase motifs and in a second putative NTB domain in the C terminus of CSB. A single or double amino acid change in the highly conserved residues of motifs Ia, III, V, and VI abolished the function of the CSB protein in survival, RNA synthesis recovery, and apoptosis after UV and 4-NQO exposure.3 In contrast, a point mutation in the putative second NTB of CSB protein showed full complementation in its ability to repair DNA damage induced by UV light or 4-NQO.3 The pattern of resistance of different CSB mutants to gamma -radiation was similar to those of UV light and 4-NQO but more deficient in motif V and VI mutants than in motif Ia and III mutants.

The in vitro deficits in 8-OH-Gua incision observed for some mutant cell line extracts were reflected by the hypersensitivity of the cells to gamma -radiation and in the observed accumulation of 8-OH-Gua lesions in the DNA of the respective cell lines. The helicase motif contribution to 8-OH-Gua glycosylase/apurinic lyase activities paralleled the gamma -radiation resistance. Thus, the functional assays support the observation that the disruption of specific helicase motifs of CSB causes a BER defect. These results suggest that different motifs of the CSB helicase domain may function in different metabolic pathways.

Helicase superfamilies (SF1 and SF2) are composed of proteins that share similar structures and participate in processes including replication, recombination, DNA repair, transcription, and chromatin assembly (41, 42). Because there has been no previous functional analysis of the putative helicase motifs I, III, IV, V, and VI in CSB, speculation on the biochemical function of these conserved regions is largely based on information from structural and functional studies of other helicases.

Crystal structure of Escherichia coli Rep helicase revealed that motif Ia acts directly with single stranded DNA and potentially functions in the energy transduction from ATPase to DNA (43). Mutation in motif II of eIF-4A, a RNA helicase, resulted in a large decrease in the rate of ATP hydrolysis and a loss of helicase activity (44). Biochemical characterization of PcrA helicase showed that mutation of motif III affects ATP hydrolysis (45). Our study on the function of motif II of CSB in human cells using a base incision assay uncovered that this motif was not involved in BER of 8-OH-Gua and suggests that ATPase function is not essential in this process.2 Thus, BER of 8-OH-Gua may not be an energy-consuming process, or it may require energy from alternative sources. This notion is supported by the data in the current work showing that motif Ia and III mutants display normal survival after gamma -radiation, a treatment that causes oxidative DNA base damage.

Crystal structure analysis of motif V of E. coli Rep helicase and of motif V of E. coli UvrB protein suggests that this motif is involved in single-stranded DNA binding (43, 46). E. coli UvrB and eIF-4A exhibit nucleic acid binding defects when conserved motif VI residues are altered (44, 46). Based on crystal structure data, helicase motif VI is not directly involved in DNA or nucleotide binding (46, 47). However, by virtue of its close proximity to both the NTP-binding site and the DNA-binding site, it may act to communicate between these sites by mediating conformational changes associated with helicase function (41). We find that mutation in the conserved motifs V and VI of CSB caused a severe compromise of both the in vivo and in vitro end points examined. It was previously reported that helicase motif V and VI of E. coli UvrB were responsible for the enhanced catalytic activity in the presence of damaged DNA (46). Further study on the interaction of CSB and damaged DNA with our mutant cell lines might add more information.

Hydroxyl radical-mediated base modifications are among the most deleterious processes induced in DNA by ionizing radiation (48, 49). Hydroxyl radicals are produced in the hydration layer of DNA in gamma -radiated cells and induce the generation of 8-OH-Gua (50). To determine whether the deficiency in BER leads to the accumulation of 8-OH-Gua in genomic DNA, the level of the nucleoside form of 8-OH-Gua, i.e. 8-OH-dGuo in DNA was measured by liquid chromatography/mass spectrometry after exposure of cells to a low dose of gamma -radiation. The results showed an enhanced level of 8-OH-dGuo in genomic DNA after exposure of CSB null cells and two motif VI CS-B mutants to 2 Gy of gamma -radiation as compared with CS-B cells transfected with the wild type CSB gene. These data demonstrate that CSB null and motif VI mutants had compromised resistance, further supporting the conclusion that CSB plays a role in the removal of 8-OH-Gua from DNA and the importance of motif VI in this function. Recently, Le Page et al. (20) demonstrated that thymine glycol and 8-OH-Gua were removed by a TCR process that did not involve NER. It was also concluded in those studies that the repair defect in CS-B cells was due to deficient TCR alone without any defect in general genome BER (21). Our results in CSB null and certain CSB mutants suggest a deficiency in removal of 8-OH-Gua in the general genome BER because we have used a DNA oligomer containing base damage in nontranscribed DNA. This repair reflects the general genome rather than TCR. It is possible that CSB directly interacts with other proteins involved in BER, and/or it may regulate the expression of certain BER proteins via its role as transcriptional activator and its effect on chromatin assembly. gamma -Radiation introduces a variety of lesions in DNA. Many of these are base modifications, but some are direct single- or double-stranded breaks. At the doses that we have used here there are relatively few single strand breaks and almost no double-stranded breaks (51). However, we cannot exclude a contribution of the CSB protein to the repair of strand breaks via other pathways than BER.

A basal transcription defect has been observed in human CS-B lymphoblastoid cells and fibroblasts in the absence of exposure to DNA damaging agents (8). A recent study showed that CSB binding to DNA caused an alteration of the DNA conformation, a remodeling of chromatin structure, and an interaction with core histones (52), all of which occur during basal transcription (1, 53, 54). Thus, the CS phenotype may arise from a combined deficiency in DNA repair and transcription. The down-regulation of certain repair related genes in CSB null or mutant cells could indirectly lead to the incapability of BER.

We suggest that the biological functions of CSB in different DNA repair pathways may be mediated by distinct functional motifs of the protein. Our observation of increased accumulation of oxidative DNA base lesions in DNA in CS-B cells supports the notion that these lesions accumulate in CS patients and may contribute significantly to the phenotype of the disease.

    ACKNOWLEDGEMENTS

We thank Dr. S. Nyaga and A. May for advice and comments and Drs. Zeng, Opresko, and Souza-Pinto for helpful discussion. Identification of certain commercial equipment or materials does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: Dept. of Anesthesiology and Waisman Center on Mental Retardation and Development, University of Wisconsin, Madison, WI 53705.

|| To whom correspondence should be addressed: Laboratory of Molecular Gerontology, NIA, National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224. Tel.: 410-558-8223; Fax: 410-558-8157; E-mail: vbohr@nih.gov.

Published, JBC Papers in Press, October 1, 2001, DOI 10.1074/jbc.M107888200

2 R. Selzer, S. Nyaga, J. Tuo, A. May, M. Muftuoglu, M. Christiansen, E. Citterio, R. M. Brosh, Jr., and V. A. Bohr, submitted for publication.

3 M. Muftuoglu, R. Selzer, J. Tuo, R. M. Robert, Jr., and V. A. Bohr, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: CS, Cockayne syndrome; CS-A, CS group A; CS-B, CS group B; BER, base excision repair; TCR, transcription-coupled repair; NER, nucleotide excision repair; Gy, Gray; 8-OH-Gua, 8-hydroxyguanine; 8-OH-dGuo, 8-hydroxy-2'-deoxyguanosine; 5-OH-Cyt, 5-hydroxycytosine; 4-NQO, 4-nitroquinoline-1-oxide; WCE, whole cell extract; AUC, area under the curve; NTB, nucleotide-binding; RT, reverse transcription; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Friedberg, E. C. (1996) Bioessays 18, 731-738[CrossRef][Medline] [Order article via Infotrieve]
2. Nance, M. A., and Berry, S. A. (1992) Am. J. Med. Genet. 42, 68-84[CrossRef][Medline] [Order article via Infotrieve]
3. Henning, K. A., Li, L., Iyer, N., McDaniel, L. D., Reagan, M. S., Legerski, R., Schultz, R. A., Stefanini, M., Lehmann, A. R., and Mayne, L. V. (1995) Cell 82, 555-564[CrossRef][Medline] [Order article via Infotrieve]
4. Lehmann, A. R. (1982) Mutat. Res. 106, 347-356[CrossRef][Medline] [Order article via Infotrieve]
5. Troelstra, C., van Gool, A., de Wit, J., Vermeulen, W., Bootsma, D., and Hoeijmakers, J. H. (1992) Cell 71, 939-953[CrossRef][Medline] [Order article via Infotrieve]
6. Mayne, L. V., and Lehmann, A. R. (1982) Cancer Res. 42, 1473-1478[Abstract/Free Full Text]
7. Barrett, S. F., Robbins, J. H., Tarone, R. E., and Kraemer, K. H. (1991) Mutat. Res. 255, 281-291[Medline] [Order article via Infotrieve]
8. Balajee, A. S., May, A., Dianov, G. L., Friedberg, E. C., and Bohr, V. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4306-4311[Abstract/Free Full Text]
9. Balajee, A. S., and Bohr, V. A. (2000) Gene (Amst.) 250, 15-30[CrossRef][Medline] [Order article via Infotrieve]
10. Evans, M. K., and Bohr, V. A. (1994) Mutat. Res. 314, 221-231[CrossRef][Medline] [Order article via Infotrieve]
11. Gunz, D., Hess, M. T., and Naegeli, H. (1996) J. Biol. Chem. 271, 25089-25098[Abstract/Free Full Text]
12. Mellon, I., Bohr, V. A., Smith, C. A., and Hanawalt, P. C. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 8878-8882[Abstract/Free Full Text]
13. van Hoffen, A., Natarajan, A. T., Mayne, L. V., van Zeeland, A. A., Mullenders, L. H., and Venema, J. (1993) Nucleic Acids Res. 21, 5890-5895[Abstract/Free Full Text]
14. Venema, J., Mullenders, L. H., Natarajan, A. T., van Zeeland, A. A., and Mayne, L. V. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4707-4711[Abstract/Free Full Text]
15. Citterio, E., Van, D. B., V, Schnitzler, G., Kanaar, R., Bonte, E., Kingston, R. E., Hoeijmakers, J. H., and Vermeulen, W. (2000) Mol. Cell. Biol. 20, 7643-7653[Abstract/Free Full Text]
16. Kipling, D., and Faragher, R. G. (1997) Mol. Pathol. 50, 234-241[Abstract/Free Full Text]
17. Dianov, G., Bischoff, C., Piotrowski, J., and Bohr, V. A. (1998) J. Biol. Chem. 273, 33811-33816[Abstract/Free Full Text]
18. Dianov, G., Bischoff, C., Sunesen, M., and Bohr, V. A. (1999) Nucleic Acids Res. 27, 1365-1368[Abstract/Free Full Text]
19. Cooper, P. K., and Leadon, S. A. (1994) Ann. N. Y. Acad. Sci. 726, 330-332[Medline] [Order article via Infotrieve]
20. Le Page, F., Klungland, A., Barnes, D. E., Sarasin, A., and Boiteux, S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8397-8402[Abstract/Free Full Text]
21. Le Page, F., Kwoh, E. E., Avrutskaya, A., Gentil, A., Leadon, S. A., Sarasin, A., and Cooper, P. K. (2000) Cell 101, 159-171[CrossRef][Medline] [Order article via Infotrieve]
22. Leadon, S. A., and Cooper, P. K. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10499-10503[Abstract/Free Full Text]
23. Troelstra, C., Odijk, H., de Wit, J., Westerveld, A., Thompson, L. H., Bootsma, D., and Hoeijmakers, J. H. (1990) Mol. Cell. Biol. 10, 5806-5813[Abstract/Free Full Text]
24. Eisen, J. A., Sweder, K. S., and Hanawalt, P. C. (1995) Nucleic Acids Res. 23, 2715-2723[Abstract/Free Full Text]
25. Selby, C. P., and Sancar, A. (1997) J. Biol. Chem. 272, 1885-1890[Abstract/Free Full Text]
26. Pazin, M. J., and Kadonaga, J. T. (1997) Cell 88, 737-740[CrossRef][Medline] [Order article via Infotrieve]
27. Brosh, R. M. J., Balajee, A. S., Selzer, R. R., Sunesen, M., De Santis, L. P., and Bohr, V. A. (1999) Mol. Biol. Cell 10, 3583-3594[Abstract/Free Full Text]
28. Mayne, L. V., Priestley, A., James, M. R., and Burke, J. F. (1986) Exp. Cell Res. 162, 530-538[CrossRef][Medline] [Order article via Infotrieve]
29. Kunkel, T. A., Bebenek, K., and McClary, J. (1991) Methods Enzymol. 204, 125-139[Medline] [Order article via Infotrieve]
30. Mallery, D. L., Tanganelli, B., Colella, S., Steingrimsdottir, H., van Gool, A. J., Troelstra, C., Stefanini, M., and Lehmann, A. R. (1998) Am. J. Hum. Genet. 62, 77-85[CrossRef][Medline] [Order article via Infotrieve]
31. Manley, J. L., Fire, A., Samuels, M., and Sharp, P. A. (1983) Methods Enzymol. 101, 568-582[Medline] [Order article via Infotrieve]
32. Piekoszewski, W., and Gubala, W. (2000) Pol. J. Pharmacol. 52, 389-395[Medline] [Order article via Infotrieve]
33. Dianov, G., and Lindahl, T. (1991) Nucleic Acids Res. 19, 3829-3833[Abstract/Free Full Text]
34. Dizdaroglu, M., Jaruga, P., and Rodriguez, H. (2001) Nucleic Acids Res. 29, E12
35. Balajee, A. S., DeSantis, L. P., Brosh, R. M. J., Selzer, R., and Bohr, V. A. (2000) Oncogene 19, 477-489[CrossRef][Medline] [Order article via Infotrieve]
36. Miller, S. A., Dykes, D. D., and Polesky, H. F. (1988) Nucleic Acids Res. 16, 1215[Free Full Text]
37. Snyderwine, E. G., and Bohr, V. A. (1992) Cancer Res. 52, 4183-4189[Abstract/Free Full Text]
38. van Oosterwijk, M. F., Versteeg, A., Filon, R., van Zeeland, A. A., and Mullenders, L. H. (1996) Mol. Cell. Biol. 16, 4436-4444[Abstract]
39. Cooper, P. K., Nouspikel, T., Clarkson, S. G., and Leadon, S. A. (1997) Science 275, 990-993[Abstract/Free Full Text]
40. Sunesen, M., Selzer, R. R., Brosh, R. M., Balajee, A. S., Stevnsner, T., and Bohr, V. A. (2000) Nucleic Acids Res. 28, 3151-3159[Abstract/Free Full Text]
41. Hall, M. C., and Matson, S. W. (1999) Mol. Microbiol. 34, 867-877[CrossRef][Medline] [Order article via Infotrieve]
42. Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1989) Nucleic Acids Res. 17, 4713-4730[Abstract/Free Full Text]
43. Korolev, S., Hsieh, J., Gauss, G. H., Lohman, T. M., and Waksman, G. (1997) Cell 90, 635-647[CrossRef][Medline] [Order article via Infotrieve]
44. Pause, A., and Sonenberg, N. (1992) EMBO J. 11, 2643-2654[Medline] [Order article via Infotrieve]
45. Dillingham, M. S., Soultanas, P., and Wigley, D. B. (1999) Nucleic Acids Res. 27, 3310-3317[Abstract/Free Full Text]
46. Moolenaar, G. F., Visse, R., Ortiz-Buysse, M., Goosen, N., and Van de Putte, P. (1994) J. Mol. Biol. 240, 294-307[CrossRef][Medline] [Order article via Infotrieve]
47. Yao, N., Hesson, T., Cable, M., Hong, Z., Kwong, A. D., Le, H. V., and Weber, P. C. (1997) Nat. Struct. Biol. 4, 463-467[CrossRef][Medline] [Order article via Infotrieve]
48. Dizdaroglu, M. (1985) Biochemistry 24, 4476-4481[CrossRef][Medline] [Order article via Infotrieve]
49. Douki, T., Martini, R., Ravanat, J. L., Turesky, R. J., and Cadet, J. (1997) Carcinogenesis 18, 2385-2391[Abstract/Free Full Text]
50. Ohshima, H., Iida, Y., Matsuda, A., and Kuwabara, M. (1996) J. Radiat. Res. (Tokyo) 37, 199-207[Medline] [Order article via Infotrieve]
51. Tabocchini, M. A., Rothkamm, K., Signoretti, C., Risse, J., Sapora, O., and Lobrich, M. (2000) Mutat. Res. 461, 71-82[Medline] [Order article via Infotrieve]
52. Citterio, E., Vermeulen, W., and Hoeijmakers, J. H. (2000) Cell 101, 447-450[CrossRef][Medline] [Order article via Infotrieve]
53. Friedberg, E. C. (1996) Annu. Rev. Biochem. 65, 15-42[CrossRef][Medline] [Order article via Infotrieve]
54. van Gool, A. J., Citterio, E., Rademakers, S., van Os, R., Vermeulen, W., Constantinou, A., Egly, J. M., Bootsma, D., and Hoeijmakers, J. H. (1997) EMBO J. 16, 5955-5965[CrossRef][Medline] [Order article via Infotrieve]
55. May, A., and Bohr, V. A. (2000) B. B. R. C. 269, 433-437


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Muftuoglu, N. C. de Souza-Pinto, A. Dogan, M. Aamann, T. Stevnsner, I. Rybanska, G. Kirkali, M. Dizdaroglu, and V. A. Bohr
Cockayne Syndrome Group B Protein Stimulates Repair of Formamidopyrimidines by NEIL1 DNA Glycosylase
J. Biol. Chem., April 3, 2009; 284(14): 9270 - 9279.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Maynard, A. M. Swistowska, J. W. Lee, Y. Liu, S.-T. Liu, A. B. Da Cruz, M. Rao, N. C. de Souza-Pinto, X. Zeng, and V. A. Bohr
Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage
Stem Cells, September 1, 2008; 26(9): 2266 - 2274.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
C F Arlett, M H L Green, P B Rogers, A R Lehmann, and P N Plowman
Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts
Br. J. Radiol., January 1, 2008; 81(961): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M. Pastoriza-Gallego, J. Armier, and A. Sarasin
Transcription through 8-oxoguanine in DNA repair-proficient and Csb /Ogg1 DNA repair-deficient mouse embryonic fibroblasts is dependent upon promoter strength and sequence context
Mutagenesis, September 1, 2007; 22(5): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Z. Imam, F. E. Indig, W.-H. Cheng, S. P. Saxena, T. Stevnsner, D. Kufe, and V. A. Bohr
Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
Nucleic Acids Res., August 1, 2007; 35(15): 4941 - 4951.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H.-K. Wong, M. Muftuoglu, G. Beck, S. Z. Imam, V. A. Bohr, and D. M. Wilson III
Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates
Nucleic Acids Res., June 12, 2007; (2007) gkm404v1.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
I. M. Kooter, J. L. A. Pennings, P. H. B. Fokkens, D. L. A. C. Leseman, A. J. F. Boere, M. E. Gerlofs-Nijland, F. R. Cassee, J. A. C. Schalk, T. J. H. Orzechowski, M. M. Schaap, et al.
Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status
J Appl Physiol, March 1, 2007; 102(3): 1185 - 1192.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Tuo, B. Ning, C. M. Bojanowski, Z.-N. Lin, R. J. Ross, G. F. Reed, D. Shen, X. Jiao, M. Zhou, E. Y. Chew, et al.
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition
PNAS, June 13, 2006; 103(24): 9256 - 9261.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Thorslund, C. von Kobbe, J. A. Harrigan, F. E. Indig, M. Christiansen, T. Stevnsner, and V. A. Bohr
Cooperation of the Cockayne Syndrome Group B Protein and Poly(ADP-Ribose) Polymerase 1 in the Response to Oxidative Stress
Mol. Cell. Biol., September 1, 2005; 25(17): 7625 - 7636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Liu, B. Xu, T. A. Cavalieri, and C. E. Hock
Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2719 - H2727.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Horibata, Y. Iwamoto, I. Kuraoka, N. G. J. Jaspers, A. Kurimasa, M. Oshimura, M. Ichihashi, and K. Tanaka
From The Cover: Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome
PNAS, October 26, 2004; 101(43): 15410 - 15415.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. de Waard, J. de Wit, J.-O. Andressoo, C. T. M. van Oostrom, B. Riis, A. Weimann, H. E. Poulsen, H. van Steeg, J. H. J. Hoeijmakers, and G. T. J. van der Horst
Different Effects of CSA and CSB Deficiency on Sensitivity to Oxidative DNA Damage
Mol. Cell. Biol., September 15, 2004; 24(18): 7941 - 7948.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Tuo, N. Tuaillon, D. Shen, and C.-C. Chan
Endotoxin-Induced Uveitis in Cyclooxygenase-2-Deficient Mice
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2306 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. L. Peterson and J. Cote
Cellular machineries for chromosomal DNA repair
Genes & Dev., March 15, 2004; 18(6): 602 - 616.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. P. Cheadle and J. R. Sampson
Exposing the MYtH about base excision repair and human inherited disease
Hum. Mol. Genet., October 15, 2003; 12(90002): R159 - 165.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Flohr, A. Burkle, J. P. Radicella, and B. Epe
Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein
Nucleic Acids Res., September 15, 2003; 31(18): 5332 - 5337.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. Shirkey, N. J. McMaster, S. C. Smith, D. J. Wright, H. Rodriguez, P. Jaruga, M. Birincioglu, R. F. Helm, and M. Potts
Genomic DNA of Nostoc commune (Cyanobacteria) becomes covalently modified during long-term (decades) desiccation but is protected from oxidative damage and degradation
Nucleic Acids Res., June 15, 2003; 31(12): 2995 - 3005.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. TUO, P. JARUGA, H. RODRIGUEZ, V. A. BOHR, and M. DIZDAROGLU
Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress
FASEB J, April 1, 2003; 17(6): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Christiansen, T. Stevnsner, C. Modin, P. M. Martensen, R. M. Brosh Jr, and V. A. Bohr
Functional consequences of mutations in the conserved SF2 motifs and post-translational phosphorylation of the CSB protein
Nucleic Acids Res., February 1, 2003; 31(3): 963 - 973.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. Parker, R. N. O'Meally, D. H. Oliver, L. Hua, W. G. Nelson, T. L. DeWeese, and J. R. Eshleman
8-Hydroxyguanosine Repair Is Defective in Some Microsatellite Stable Colorectal Cancer Cells
Cancer Res., December 15, 2002; 62(24): 7230 - 7233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tuo, P. Jaruga, H. Rodriguez, M. Dizdaroglu, and V. A. Bohr
The Cockayne Syndrome Group B Gene Product Is Involved in Cellular Repair of 8-Hydroxyadenine in DNA
J. Biol. Chem., August 16, 2002; 277(34): 30832 - 30837.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45772    most recent
M107888200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement